Oxford scientists are preparing to rapidly produce new versions of their vaccine to combat emerging more contagious Covid-19 variants discovered in the UK, South Africa and Brazil, The Telegraph reported.
Report: AstraZeneca’s Covid-19 Vaccine Generates Antibodies and T-Cells Against the Virus in Phase I Trial
"Operation Warp Speed" Initiative, Antibodies, Clinical Trials, Coronavirus Disease 2019 (COVID-19), COVID-19 Vaccines, Data, Oxford University’s Jenner Institute, R&D, Shares, T-Cells, The Lancet, The Telegraph, United KingdomPhase I data from the Covid-19 vaccine under development by AstraZeneca and Oxford University’s Jenner Institute is showing a robust defense against the novel coronavirus that has infected more than 13 million people across the globe.